Blix, E. S., Irish, J. M., Husebekk, A., Delabie, J., Tierens, A. M., Myklebust, J. H., & Kolstad, A. (2012). Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients.
Chicago Style citaatBlix, Egil S., Jonathan M. Irish, Anne Husebekk, Jan Delabie, Anne M. Tierens, June H. Myklebust, en Arne Kolstad. Altered BCR and CD40 Signalling Are Associated With Clinical Outcome in Small Lymphocytic Lymphoma/chronic Lymphocytic Leukaemia and Marginal Zone Lymphoma Patients. 2012.
MLA citatieBlix, Egil S., et al. Altered BCR and CD40 Signalling Are Associated With Clinical Outcome in Small Lymphocytic Lymphoma/chronic Lymphocytic Leukaemia and Marginal Zone Lymphoma Patients. 2012.